Saizen’s Role in Enhancing Growth in Children with Juvenile Idiopathic Arthritis
Reading Time: 2 minutes Introduction Juvenile Idiopathic Arthritis (JIA) is a chronic autoimmune disorder that primarily affects children and adolescents. One of the significant challenges faced by pediatric patients with JIA is growth retardation, which can lead to short stature and other developmental issues. Saizen, a recombinant human growth hormone, has emerged as a promising therapeutic option to mitigate these growth deficits. This article explores the use of Saizen in children with JIA and its effects on growth. Understanding Juvenile Idiopathic Arthritis Juvenile Idiopathic Arthritis is the most common form of arthritis in children, characterized by joint inflammation that can persist for months or...